Últimas noticias sobre L3Harris Technologies (NYSE:LHX) Bolsa

L3HARRIS TECHNOLOGIES INC

L3Harris Technologies

L3Harris Technologies provides products primarily for the command, control, communications, computers, intelligence, surveillance, and reconnaissance, or C4ISR, market. The firm produces uncrewed aerial vehicles, sensors, and avionics, provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure. In July 2023, the company acquired Aerojet Rocketdyne, a key supplier of rocket motors used in the space industry and to propel munitions.

Palantir,Technologies,Japan,Logo,,Tokyo,,Japan,2024,Sep.15

Equities

News

Markets

PLTR

Palantir desarrolla un vehículo militar con IA para el programa TITAN. ¿Qué impacto tendrá en futuras guerras?

Palantir (PLTR) impulsa su expansión militar con un vehículo de combate autónomo con IA

Ukraine Aid bill

Global

Economics

Trump amenaza con sanciones masivas a Rusia mientras Ucrania avanza en acuerdos económicos clave. ¿Cómo afectará esto a la región?

Estados Unidos reanuda ayuda a Ucrania tras aceptar un alto el fuego de 30 días

Government

SPACE

Politics

Tech

El multimillonario Elon Musk podría obtener un contrato de 2400 millones de dólares para Starlink, financiado por la FAA.

Elon Musk y Starlink podrían recibir un contrato millonario de la FAA: ¿Beneficio de su amistad con Trump?

B. Riley Securities analyst Mike Crawford maintains TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) with a Buy and raises the price target from $36 to $50.

Price Target

Analyst Ratings

TTMI

B. Riley Securities Maintains Buy on TTM Technologies, Raises Price Target to $50

BTCT

BTC Digital Announces Transformative, Strategic Shift To Fully Embrace Ethereum As Core Asset And Operational Foundation; Closes $6M Financing Round, Adds New $1M ETH Position

Truist Securities analyst Matthew Coad maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Buy and raises the price target from $58 to $72.

AFRM

Truist Securities Maintains Buy on Affirm Holdings, Raises Price Target to $72

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.
Shares of Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) fell sharply in pre-market trading after the company issued third-quarter <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46447307/abbott-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">adjusted EPS guidance below estimates.</a>
Abbott posted adjusted earnings of $1.26 per share, beating market estimates of $1.25 per share. The company's sales came in at $11.142 billion versus expectations of $11.068 billion.
Abbott Laboratories said it sees third-quarter adjusted EPS of $1.28 to $1.32, versus estimates of $1.34.
Abbott shares dipped 5.1% to $125.02 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares dipped 11.2% to $14.16 in pre-market trading.  Nuwellis shares jumped 131% on Wednesday after the company announced it secured a U.S. patent for an extracorporeal blood filtering machine and methods.</li>
<li>Pitanium Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTNM#NASDAQ">PTNM</a>) declined 7.3% to $12.41 in pre-market trading.</li>
<li>Jade Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBIO#NASDAQ">JBIO</a>) fell 7% to $8.20 in pre-market trading.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) dipped 7% to $54.37 in pre-market trading after the company announced a $500 million proposed public offering.</li>
<li>Ingredion Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) shares slipped 6.8% to $126.07 in pre-market trading.</li>
<li>Guess?, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) declined 5.8% to $12.00 in pre-market trading.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) fell 4.8% to $2.55 in pre-market trading.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46439944/jim-cramer-takes-a-pass-on-this-money-losing-utilities-stock">Jim Cramer &#8216;Takes A Pass&#8217; On This Money-Losing Utilities Stock</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Movers

Trading Ideas

INGR

JBIO

NUWE

PTNM

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

WIIM

VERI

Veritone shares are trading higher after the company announced it has achieved "awardable" status with the Department of Defense's P1 solutions marketplace.

Truist Securities analyst Barry Jonas maintains Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) with a Buy and raises the price target from $105 to $120.

MCRI

Truist Securities Maintains Buy on Monarch Casino & Resort, Raises Price Target to $120

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy and maintains $5 price target.

VNRX

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

BMNR

BitMine Immersion Now Holds ~$1B Of Ethereum, Exceeding Initial $250M PIPE Proceeds By Over 300%

Regulations

OKLO

Oklo Completes US Nuclear Regulatory Commission's Pre-Application Readiness Assessment For Phase 1 Of Combined License Application For Aurora Powehouse

Oppenheimer analyst Chris Kotowski maintains Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) with a Outperform and lowers the price target from $57 to $55.

Oppenheimer Maintains Outperform on Bank of America, Lowers Price Target to $55

As the global economy navigates a post-pandemic world, investors are keenly observing evolving market dynamics, including shifts in consumer behavior <a href="https://www.benzinga.com/tech">and technological advancements.</a>
On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/07/16/final-trades-johnson-johnson-ice-and-the-ibit.html">Halftime Report Final Trades</a>,&#8221; Sarat Sethi, managing partner at DCLA, said he is sticking with Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) amid a positive <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46449538/johnson-johnson-raises-fy25-forecast-joins-rigetti-computing-unity-software-brighthouse-fina">earnings report</a>.
On Wednesday, Johnson &amp; Johnson raised its FY2025 earnings guidance. The company reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68. The pharmaceutical giant reported sales of $23.74 billion, up 5.8% year-over-year and beating the consensus estimate of $22.85 billion.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, named iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) as his final trade.
Don't forget to check out our<a href="https://www.benzinga.com/premarket/"> premarket coverage here</a>
Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked Intercontinental Exchange, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) as his final trade.
Lending support to his choice, Piper Sandler analyst Patrick Moley maintained an Overweight rating for Intercontinental Exchange on Tuesday, raising the price target from $180 to $202.
Price Action:
<ul class="wp-block-list">
<li>Johnson &amp; Johnson shares dipped 5.5% to close at $78.86 on Tuesday.</li>
<li>iShares Bitcoin Trust ETF gained 2.5% during the session.</li>
<li>Intercontinental Exchange shares rose 0.6% to close at $180.80 during the session.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46439944/jim-cramer-takes-a-pass-on-this-money-losing-utilities-stock">Jim Cramer &#8216;Takes A Pass&#8217; On This Money-Losing Utilities Stock</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

IBIT

Johnson & Johnson, Intercontinental Exchange And Bitcoin ETF On CNBC's 'Final Trades'

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) with a Buy and maintains $4 price target.

QNCX

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

DGXX

Digi Power X shares are trading higher after the company announced it has executed a definitive purchase order with Super Micro Computer to supply NVIDIA B200-powered systems.

Oppenheimer analyst Noah Kaye maintains Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) with a Outperform and raises the price target from $132 to $140.

Oppenheimer Maintains Outperform on Vertiv Holdings, Raises Price Target to $140

Oppenheimer analyst Kristen Owen maintains Trimble (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>) with a Outperform and raises the price target from $81 to $88.

TRMB

Oppenheimer Maintains Outperform on Trimble, Raises Price Target to $88

SPAI

Safe Pro Group shares are trading higher after Litchfield Hills initiated coverage on the stock with a Buy rating and announced a price target of $8.

Oppenheimer analyst Noah Kaye maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Outperform and raises the price target from $304 to $371.

Oppenheimer Maintains Outperform on Rockwell Automation, Raises Price Target to $371

Guidance

Pagaya Sees Prelim. Q2 Revenue ~$326M vs Guidance Of $290M-$310M

NioCorp shares are trading lower after the company announced a proposed public offering.

Oppenheimer analyst Noah Kaye maintains Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) with a Outperform and raises the price target from $600 to $650.

Oppenheimer Maintains Outperform on Lennox Intl, Raises Price Target to $650

Press Releases

L3Harris Sets Date for First Quarter 2025 Earnings Release

NUBURU's (BURU) Strategic Leap: Expanding into Defense Technology with Innovative Laser Solutions

L3Harris Delivers First Missionized Skyraider II Aircraft to Support Special Operations

L3Harris Expands Indiana Facility to Support America's Golden Dome

L3Harris Announces Quarterly Dividend

L3Harris Technologies Reports First Quarter 2025 Results, Updates 2025 Guidance

L3Harris to Present at Three Upcoming Investor Conferences

L3Harris Receives $214 Million in Orders to Support German Armed Forces

L3Harris Marks Major Milestone for New Solid Rocket Motor 'Factories of the Future' in Virginia

Comments

L3Harris Technologies

Noticias

Últimas noticias sobre L3Harris Technologies (NYSE:LHX) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL